Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04214288
Title A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Cancer (SERENA-2)
Acronym SERENA-2
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | CAN | BEL

No variant requirements are available.